The startup has developed a vapor thermal therapy system that provides a non-invasive treatment for abnormal uterine bleeding (AUB). This system reduces recovery times compared to traditional operating room procedures, making it a cost-effective option for a wider range of women.
Funding
Funding not disclosed
Founders
Product
Problem
Abnormal Uterine Bleeding (AUB) significantly impacts a woman's quality of life, affecting work, education, and personal relationships. Current treatment options may not provide adequate relief, leaving many patients undertreated or requiring invasive surgical procedures like hysterectomies.
Solution
Aqua Therapeutics is developing a proprietary Vapor Thermal Therapy (VTT) system designed to provide an improved, office-based, and cost-effective solution for AUB. The system utilizes a proprietary method of vapor creation and delivery to achieve efficient ablation with short treatment times. The VTT system is designed to be cycle-independent, providing gynecologists flexibility in treating patients, and does not require uterine wall contact, potentially allowing treatment of complicated uterine configurations. The platform uses minimal fluid, eliminating the need for fluid collection or monitoring.
Target Audience
The primary target audience includes gynecologists seeking an effective, office-based solution for treating women with Abnormal Uterine Bleeding (AUB).
Features
- Proprietary vapor creation and delivery system for efficient thermal ablation.
- Cycle-independent treatment protocol for scheduling flexibility.
- Non-wall contact ablation technology to maximize uterine treatment while preserving critical structures.
- Low device profile designed for smooth placement and ease-of-use.
- Minimal fluid usage, eliminating the need for fluid collection or monitoring.
- Short treatment time of less than 90 seconds.
- Designed to leverage existing reimbursement pathways globally.